PT2844083T - Utilização de extrato de tomate como agente anti-hipertensivo e processo para produzir extrato de tomate livre de açúcar solúvel em água - Google Patents

Utilização de extrato de tomate como agente anti-hipertensivo e processo para produzir extrato de tomate livre de açúcar solúvel em água

Info

Publication number
PT2844083T
PT2844083T PT13719356T PT13719356T PT2844083T PT 2844083 T PT2844083 T PT 2844083T PT 13719356 T PT13719356 T PT 13719356T PT 13719356 T PT13719356 T PT 13719356T PT 2844083 T PT2844083 T PT 2844083T
Authority
PT
Portugal
Prior art keywords
tomato extract
water soluble
making water
soluble sugar
antihypertensive agent
Prior art date
Application number
PT13719356T
Other languages
English (en)
Inventor
K Duttaroy Asim
Original Assignee
Univ Oslo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oslo filed Critical Univ Oslo
Publication of PT2844083T publication Critical patent/PT2844083T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/55—Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
PT13719356T 2012-04-23 2013-04-22 Utilização de extrato de tomate como agente anti-hipertensivo e processo para produzir extrato de tomate livre de açúcar solúvel em água PT2844083T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261636813P 2012-04-23 2012-04-23

Publications (1)

Publication Number Publication Date
PT2844083T true PT2844083T (pt) 2018-11-12

Family

ID=48225147

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13719356T PT2844083T (pt) 2012-04-23 2013-04-22 Utilização de extrato de tomate como agente anti-hipertensivo e processo para produzir extrato de tomate livre de açúcar solúvel em água

Country Status (15)

Country Link
US (3) US20150132371A1 (pt)
EP (1) EP2844083B1 (pt)
JP (4) JP2015515493A (pt)
CN (2) CN104363774A (pt)
AU (1) AU2013252637B2 (pt)
CA (1) CA2881555C (pt)
DK (1) DK2844083T3 (pt)
ES (1) ES2692158T3 (pt)
HK (1) HK1205880A1 (pt)
IN (1) IN2014MN02392A (pt)
NZ (1) NZ630482A (pt)
PL (1) PL2844083T3 (pt)
PT (1) PT2844083T (pt)
TR (1) TR201815457T4 (pt)
WO (1) WO2013163057A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013252637B2 (en) 2012-04-23 2016-12-22 Provexis Natural Products Limited Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
EP3534725A1 (en) 2016-11-02 2019-09-11 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution
CN109380728B (zh) * 2018-10-17 2022-03-22 汤臣倍健股份有限公司 一种具有辅助降血压功效的组合物及保健食品
WO2020166494A1 (ja) * 2019-02-15 2020-08-20 国立大学法人信州大学 血圧低下作用を有するナス由来組成物
CN110638902A (zh) * 2019-09-30 2020-01-03 白冬平 番茄提取物在制备降血压药物中的应用及其降血压组合物
DE102020001722A1 (de) 2020-03-14 2021-09-16 DÖHLER GmbH Verfahren zur Herstellung eines aromabeladenen Gases, aromabeladenes Gas und Verwendung des aromabeladenen Gases
WO2022238727A1 (en) * 2021-05-08 2022-11-17 Momand Hossay Methods for preparing white heirloom tomato-based compositions for skin lightening via enhanced glutathione, and associated compositions thereof
CN114617920B (zh) * 2022-04-11 2023-10-13 汤臣倍健股份有限公司 一种具有改善记忆力功能的水溶性番茄提取物及其应用
GB202208323D0 (en) * 2022-06-07 2022-07-20 Provexis Natural Products Ltd Compostions

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6467173A (en) 1987-09-04 1989-03-13 Sanei Kagaku Kogyo Kk Preparation of vegetable or fruit juices
JP2722670B2 (ja) * 1989-05-30 1998-03-04 ライオン株式会社 高血圧症予防用飲食品及びその製造方法
JP2997358B2 (ja) 1992-01-30 2000-01-11 ポーラ化成工業株式会社 皮膚外用剤
ES2125342T3 (es) 1992-07-30 1999-03-01 Cal Int Ltd Esteres y combinaciones de un nitrato organico y de un salicilato.
US5502038A (en) 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
JP2905725B2 (ja) * 1995-07-01 1999-06-14 カゴメ株式会社 トマト由来の食品組成物
FR2759904B1 (fr) 1997-02-25 2000-01-28 Alma Heny Reza Compositions a usage cosmetique et/ou pharmaceutique et/ou dermatologique et leurs procedes de fabrication
DE19720767A1 (de) 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen
GB9808796D0 (en) 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
ES2197573T3 (es) 1998-09-02 2004-01-01 Unilever N.V. Productos de tomate enriquecidos en beta-ciclocitral.
WO2000021507A2 (de) 1998-10-12 2000-04-20 Andreas Bockelmann Pharmazeutisch wirksame zusammensetzung
CN1352941A (zh) 2000-11-11 2002-06-12 吉建军 亚油酸胶囊
US20040191790A1 (en) 2001-05-04 2004-09-30 Tomassen Monica Magdalena Maria Novel regulatory protein
DE10300049A1 (de) 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
ITMI20020632A1 (it) 2002-03-27 2003-09-29 Indena Spa Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
EP1559421B1 (en) 2002-11-06 2016-07-27 Kao Corporation Blood circulation promoting agent
EP2213294A1 (en) 2003-03-27 2010-08-04 Unigen Inc. Use of compositions comprising tricin
JP4571783B2 (ja) 2003-04-14 2010-10-27 林原 健 抗微生物剤
US20040223962A1 (en) 2003-05-07 2004-11-11 Riordan Neil H. Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
EP1481669A1 (en) 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
ATE424898T1 (de) 2003-08-21 2009-03-15 Nestec Sa Natürliche lycopenkonzentrate und verfahren zur herstellung
JP2004137287A (ja) * 2003-12-08 2004-05-13 Kao Corp 高血圧症予防・治療剤
FR2871378B1 (fr) 2004-06-15 2007-03-30 Seppic Sa Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens
EP1640001A1 (en) 2004-09-24 2006-03-29 New Pharma Investments Holding Composition against cardiovascular diseases
CN100488535C (zh) 2004-12-09 2009-05-20 郭富凤 一种番茄红素混合物
US7419960B2 (en) 2005-01-07 2008-09-02 Hong Kong Baptist University Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescens
JP2006193435A (ja) 2005-01-11 2006-07-27 Kagome Co Ltd 疲労改善剤
GB0502985D0 (en) * 2005-02-14 2005-03-16 Provexis Ltd Therapeutic uses of tomato extracts
WO2006094120A2 (en) 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
JP4260158B2 (ja) 2005-07-07 2009-04-30 長谷川香料株式会社 トマトジュース濃縮物の製造方法およびトマト風味組成物
US20070082071A1 (en) 2005-10-07 2007-04-12 Willimann John A Composition for controlling the respiratory effects of inhaled pollutants & allergens
AT503521A1 (de) 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
GB0610790D0 (en) 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts
US20080009449A1 (en) 2006-07-07 2008-01-10 Kailash Prasad Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
WO2008080162A2 (en) 2006-12-22 2008-07-03 The Johns Hopkins University Anti-cholesterolemic compounds and methods of use
US8759327B2 (en) 2007-04-16 2014-06-24 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
EP2036568A1 (en) 2007-09-12 2009-03-18 Nestec S.A. Wolfberries and inflammation
JP2009240191A (ja) 2008-03-31 2009-10-22 Shimizu Shoko Kaigisho 光照射によるリグナン類・リグニン類合成系遺伝子の発現増強
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
GB0819958D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
EP2515925A4 (en) 2009-12-24 2014-05-21 Univ Mcgill COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE HEALTH EFFECTS CAUSED BY THE ENVIRONMENT
JP6058872B2 (ja) * 2010-01-18 2017-01-11 キッコーマン株式会社 抗ストレス作用を有するｇａｂａ高含有トマト由来組成物
AU2013252637B2 (en) 2012-04-23 2016-12-22 Provexis Natural Products Limited Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
EP3534725A1 (en) 2016-11-02 2019-09-11 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution

Also Published As

Publication number Publication date
EP2844083A1 (en) 2015-03-11
PL2844083T3 (pl) 2018-12-31
CA2881555A1 (en) 2013-10-31
JP2019038844A (ja) 2019-03-14
WO2013163057A1 (en) 2013-10-31
US20180271926A1 (en) 2018-09-27
US10864241B2 (en) 2020-12-15
JP2021008474A (ja) 2021-01-28
JP2023009053A (ja) 2023-01-19
AU2013252637A1 (en) 2014-12-04
CN104363774A (zh) 2015-02-18
CN107397830A (zh) 2017-11-28
US20150132371A1 (en) 2015-05-14
EP2844083B1 (en) 2018-07-25
NZ630482A (en) 2016-11-25
CA2881555C (en) 2021-10-19
JP2015515493A (ja) 2015-05-28
HK1205880A1 (en) 2015-12-31
IN2014MN02392A (pt) 2015-08-21
DK2844083T3 (en) 2018-11-12
US20210236578A1 (en) 2021-08-05
AU2013252637B2 (en) 2016-12-22
ES2692158T3 (es) 2018-11-30
TR201815457T4 (tr) 2018-11-21

Similar Documents

Publication Publication Date Title
HK1205880A1 (en) Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
HK1202308A1 (en) Water soluble compositions incorporating enzymes, and method of making same
HK1209157A1 (en) Extraction, preparation, and application of plant micro-ribonucleic acid
ZA201503332B (en) Water treatment composition and method of using same
EP2831001A4 (en) COMPOSITION FOR THE TREATMENT OF WATER AND METHOD FOR USE
HK1207824A1 (en) Polymorph compositions, methods of making, and uses thereof
PL2797436T3 (pl) Sposoby wytwarzania napojów na bazie roślin
HK1209031A1 (en) Polysaccharide compositions and methods of use
EP2896694A4 (en) GLUCIDE OXIDASE AND METHOD FOR PRODUCTION AND USE
IL237616A0 (en) A process for converting nitro derivatives to amines
EP2828276A4 (en) RICH RUTIN EXTRACT AND MANUFACTURING METHOD THEREOF
SG10201706453XA (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
EP2928456A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
HK1216891A1 (zh) 苔蘚素組合物、其製備方法和用途
EP2750688A4 (en) METHODS AND COMPOSITIONS FOR PROMOTING GLUCOSE HOMEMYSTASIS
EP2821084A4 (en) PROCESS FOR INCREASING THE WATER SOLUBILITY OF A WEAK SOLUBLY SUBSTANCE
EP2870133A4 (en) TETRAHYDRO ISOHUMULOD DERIVATIVES, METHOD FOR THE PREPARATION AND USE THEREOF
IL231490A0 (en) Preparations and methods for the production and use of human cholinesterases
EP2902034A4 (en) USE OF ALCOHOL LEXTRACT FROM LONG SERIES
EP2578568A4 (en) PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED FLUOROPYRROLIDINE DERIVATIVES
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
EP2861586A4 (en) FORMS OF VILAZODONE AND METHODS OF PREPARATION THEREOF
HK1169392A1 (en) Method to prepare 3-acetylisoquinoline and derivatives thereof 3-
PL392488A1 (pl) Sposób jednoczesnego wytwarzania 3ß,7α-dihydroksyandrost-5-en-17-onu i 3ß,7ß-dihydroksyandrost-5-en-17-onu